Jubilant Organosys net up 33%

CORPORATE SCORECARD

Jubilant Organosys, a leading custom research and manufacturing services player in the pharmaceutical segment, recorded 32.5 per cent growth in net profit for the quarter ended March 31, 2007, at Rs 63.8 crore against the corresponding quarter last year.

On a standalone basis, the profit after tax was Rs 69.6 crore compared with Rs 47.4 crore, a growth of 46.8 per cent. Net sales for the quarter improved by 9.6 per cent at Rs 463.3 crore.

The company's net profit for 2006-07 stood at Rs 228 crore, up by 76 per cent compared with Rs 129.7 crore of the previous year.

The net sales increased 20.7 per cent Rs 1809.7 crore compared with Rs 1499 crore in 2005-06. The company attributed the higher sales to the 41.3 per cent higher revenue from international sales at Rs 831.8 crore.

Shyam S Bhartia, chairman and managing director, said: "It has been a record year for Jubilant both in terms of revenues and earnings. The future looks even better as we are hopeful of maintaining the momentum next year. Our focus on the pharma and life science product business continues to deliver strong results, which validates not just our strategy but also our ability to create a global niche for ourselves."